88 related articles for article (PubMed ID: 35603128)
1. An investigation into human papillomavirus (HPV) vaccination for patients undergoing surgery for high-grade cervical or vulvar dysplasia.
Boyles GP; Baek J; Pandit R; Cosgrove CM; Bixel KL
Gynecol Oncol Rep; 2022 Jun; 41():101001. PubMed ID: 35603128
[TBL] [Abstract][Full Text] [Related]
2. Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data.
Joura EA; Garland SM; Paavonen J; Ferris DG; Perez G; Ault KA; Huh WK; Sings HL; James MK; Haupt RM;
BMJ; 2012 Mar; 344():e1401. PubMed ID: 22454089
[TBL] [Abstract][Full Text] [Related]
3. HPV Vaccination after Primary Treatment of HPV-Related Disease across Different Organ Sites: A Multidisciplinary Comprehensive Review and Meta-Analysis.
Di Donato V; Caruso G; Bogani G; Cavallari EN; Palaia G; Perniola G; Ralli M; Sorrenti S; Romeo U; Pernazza A; Pierangeli A; Clementi I; Mingoli A; Cassoni A; Tanzi F; Cuccu I; Recine N; Mancino P; de Vincentiis M; Valentini V; d'Ettorre G; Della Rocca C; Mastroianni CM; Antonelli G; Polimeni A; Muzii L; Palaia I
Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214697
[TBL] [Abstract][Full Text] [Related]
4. Surgical Treatment of Vulvar HSIL: Adjuvant HPV Vaccine Reduces Recurrent Disease.
Ghelardi A; Marrai R; Bogani G; Sopracordevole F; Bay P; Tonetti A; Lombardi S; Bertacca G; Joura EA
Vaccines (Basel); 2021 Jan; 9(2):. PubMed ID: 33503866
[TBL] [Abstract][Full Text] [Related]
5. The early benefits of human papillomavirus vaccination on cervical dysplasia and anogenital warts.
Smith LM; Strumpf EC; Kaufman JS; Lofters A; Schwandt M; Lévesque LE
Pediatrics; 2015 May; 135(5):e1131-40. PubMed ID: 25917991
[TBL] [Abstract][Full Text] [Related]
6. Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia.
Kenter GG; Welters MJ; Valentijn AR; Lowik MJ; Berends-van der Meer DM; Vloon AP; Essahsah F; Fathers LM; Offringa R; Drijfhout JW; Wafelman AR; Oostendorp J; Fleuren GJ; van der Burg SH; Melief CJ
N Engl J Med; 2009 Nov; 361(19):1838-47. PubMed ID: 19890126
[TBL] [Abstract][Full Text] [Related]
7. The cost-effectiveness of a quadrivalent human papillomavirus vaccine in Taiwan.
Dasbach EJ; Insinga RP; Yang YC; Pwu RF; Lac C; Elbasha EH
Asian Pac J Cancer Prev; 2008; 9(3):459-66. PubMed ID: 18990021
[TBL] [Abstract][Full Text] [Related]
8. Primary care providers human papillomavirus vaccine recommendations for the medically underserved: a pilot study in U.S. Federally Qualified Health Centers.
Roland KB; Benard VB; Greek A; Hawkins NA; Saraiya M
Vaccine; 2014 Sep; 32(42):5432-5. PubMed ID: 25131744
[TBL] [Abstract][Full Text] [Related]
9. Providers' beliefs about the effectiveness of the HPV vaccine in preventing cancer and their recommended age groups for vaccination: Findings from a provider survey, 2012.
Berkowitz Z; Malone M; Rodriguez J; Saraiya M
Prev Med; 2015 Dec; 81():405-11. PubMed ID: 26598805
[TBL] [Abstract][Full Text] [Related]
10. Human Papillomavirus Vaccination and Cervical Cytology Outcomes Among Urban Low-Income Minority Females.
Hofstetter AM; Ompad DC; Stockwell MS; Rosenthal SL; Soren K
JAMA Pediatr; 2016 May; 170(5):445-52. PubMed ID: 26974250
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus vaccine for genotypes 6, 11, 16 and 18: new drug. Cervical cancer prevention: high hopes...
Prescrire Int; 2007 Jun; 16(89):91-4. PubMed ID: 17582921
[TBL] [Abstract][Full Text] [Related]
12. HPV16/18 prevalence in high-grade cervical lesions in an Australian population offered catch-up HPV vaccination.
Cornall AM; Saville M; Pyman J; Callegari ET; Tan FH; Brotherton JML; Malloy MJ; Tabrizi SN; Wrede CD; Garland SM;
Vaccine; 2020 Sep; 38(40):6304-6311. PubMed ID: 32736938
[TBL] [Abstract][Full Text] [Related]
13. Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.
Gertig DM; Brotherton JM; Budd AC; Drennan K; Chappell G; Saville AM
BMC Med; 2013 Oct; 11():227. PubMed ID: 24148310
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic HPV vaccination after conization: A systematic review and meta-analysis.
Jentschke M; Kampers J; Becker J; Sibbertsen P; Hillemanns P
Vaccine; 2020 Sep; 38(41):6402-6409. PubMed ID: 32762871
[TBL] [Abstract][Full Text] [Related]
15. Knowledge and willingness of parents towards child girl HPV vaccination in Debre Tabor Town, Ethiopia: a community-based cross-sectional study.
Mihretie GN; Liyeh TM; Ayele AD; Belay HG; Yimer TS; Miskr AD
Reprod Health; 2022 Jun; 19(1):136. PubMed ID: 35689288
[TBL] [Abstract][Full Text] [Related]
16. Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population.
Giuliano AR; Joura EA; Garland SM; Huh WK; Iversen OE; Kjaer SK; Ferenczy A; Kurman RJ; Ronnett BM; Stoler MH; Bautista OM; Moeller E; Ritter M; Shields C; Luxembourg A
Gynecol Oncol; 2019 Jul; 154(1):110-117. PubMed ID: 30982556
[TBL] [Abstract][Full Text] [Related]
17. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
[TBL] [Abstract][Full Text] [Related]
18. Improving Human Papillomavirus (HPV) Vaccination in the Postpartum Setting.
Soon R; Sung S; Cruz MR; Chen JJ; Hiraoka M
J Community Health; 2017 Feb; 42(1):66-71. PubMed ID: 27476162
[TBL] [Abstract][Full Text] [Related]
19. Real-World Effectiveness of Human Papillomavirus Vaccination Against Vulvovaginal High-Grade Precancerous Lesions and Cancers.
Dehlendorff C; Baandrup L; Kjaer SK
J Natl Cancer Inst; 2021 Jul; 113(7):869-874. PubMed ID: 33377930
[TBL] [Abstract][Full Text] [Related]
20. HPV vaccination, knowledge, and attitudes among young cervical cancer survivors in the Deep South.
Edler M; Fernandez A; Anderson K; Pierce JY; Scalici J; Daniel CL
Vaccine; 2019 Jan; 37(4):550-557. PubMed ID: 30598386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
